ESC 365 - Discussion: connecting cardiovascular outcome trial results to clinical decision-making.

Open Access

Discussion: connecting cardiovascular outcome trial results to clinical decision-making.

Session: New dimensions in the management of cardiovascular disease in type 2 diabetes

Topic: Diabetes and the Heart

Speaker: Professor J. Deanfield (London, GB) Doctor F. Persson (Herlev, DK)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speakers

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

57 presentations

7 followers

Doctor Frederik Persson

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

2 presentations

0 follower

2 more presentations in this session

New dimensions in the management of cardiovascular disease in type 2 diabetes.

Speaker: Professor J. Deanfield (London, GB)

Debated aspects: glucagon-like peptide-1 receptor agonists for high vs low cardiovascular risk.

Speaker: Professor J. Deanfield (London, GB) Doctor F. Persson (Herlev, DK)

Access the full session

New dimensions in the management of cardiovascular disease in type 2 diabetes

Speakers: Professor J. Deanfield, Doctor F. Persson, Professor J. Deanfield, Professor J. Deanfield, Doctor F. Persson

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources